Good news for cancer-fighting ASX stocks
Three ASX stocks have enjoyed share price surges on Wednesday, after receiving positive reports on potentially lifesaving cancer treatments. Therapeutic antibody development biotech, Patrys (ASX:PAB), surged 20 per cent after receiving favourable draft reports for its two recently completed toxicology studies testing of PAT-DX1 in animals. The reports say there were no safety or tolerability … [Read more…]